Home
Welcome to BMS EU Policy
We share our story of science and show how innovation improves lives. Follow us on @BMS_EUPolicy.
_face.jpg "Illustration of a female face")
For healthcare to be sustainable, it must work for innovators, healthcare systems and patients
by Monica Shaw, SVP, European Markets, Bristol Myers Squibb
We are Bristol Myers Squibb
We are the dreamers, thinkers, and doers. We are Bristol Myers Squibb and every day we climb new heights in understanding how to treat diseases and transform the lives of patients through science.
_face.jpg#)
Who we are
We are a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
BMS in the EU
At Bristol Myers Squibb we are committed to transforming the lives of European patients, by helping to define better health policy to future proof the EU regulatory framework and to support future medical advances and innovation.
What we do
As a life science pioneer with a commitment to advancing patient health, we collaborate with EU policy makers to find solutions for patients combining data, technology and medical innovation to transform disease understanding and outcomes. We aspire to be at the center of a vibrant healthcare innovation ecosystem, where academic research centres, biotech and biopharma companies all contribute to continued scientific advancement.
we have set our sights on the most serious and challenging diseases. We seek breakthrough innovations that have the power to help patients prevail over serious diseases like cancer and diseases of the heart, the immune system, and the blood.
in 2021, our company steadily advances in the discovery and development of new medicines.
to support education and to ensure the voice of the patient is heard and considered in the design and implementation of clinical trials, as well as in the development of care solutions.
across the continent. Investment in clinical research is a major priority for Bristol Myers Squibb. Four out of our 15 R&D facilities worldwide are located in Europe.